Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

ANTH 5.53 +0.36 (6.96%)
price chart
Anthera Pharmaceuticals, Inc. Price Target Update
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) stock has received a short term price target of $ 11.5 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $9.19.
Analyst Rating Update on Anthera Pharmaceuticals Inc
Research firm Zacks has rated Anthera Pharmaceuticals (NASDAQ:ANTH) and has ranked it at 3, indicating that for the short term the shares are a hold.
Price Target Update on Anthera Pharmaceuticals Inc
Anthera Pharmaceuticals Inc (NASDAQ:ANTH): The mean short term price target for Anthera Pharmaceuticals Inc (NASDAQ:ANTH) has been established at $11.5 per share.
Healthcare Sector Movers: Unilife Corporation (UNIS), Synergy ...  WallStreet Scope
Anthera Pharmaceuticals Reaches New 1-Year High at $5.61 (ANTH)
Anthera Pharmaceuticals, Inc (NASDAQ:ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.
Anthera Pharmaceuticals Inc Analyst Rating Update
Analysts at Zacks have given a Neutral rating on Anthera Pharmaceuticals Inc (NASDAQ:ANTH) with a rank of 3. The counter has received an average rating of 1 from 2 brokerage firms.
Anthera Pharmaceuticals to Present at Cowen & Co. Healthcare Conference  MarketWatch
Anthera Pharmaceuticals Inc Price Target Update  Bar and Graph Report
Company Shares of Anthera Pharmaceuticals Inc Rally 19.27%
Shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) rose by 19.27% in the past week and 121.26% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 18.52% and the outperformance increases to 115.13% for the last 4 ...
Bullish Movements:Anthera Pharmaceuticals Inc (ANTH), Ares Capital ...  Techsonian (press release)
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Update: Anthera ...  Rock Hill Daily
Share Price of Anthera Pharmaceuticals Inc Rally 51.18%
Shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) rose by 51.18% in the past week and 85.51% for the past 4 weeks. For the past week, the counter has outperformed the S&P 500 by 48.19% and the outperformance increases to 78.65% for the past 4 ...
Most Volatile Stocks: Trulia, Inc. (TRLA), Anthera Pharmaceuticals, Inc ...  WallStreet Scope
Healthcare Stocks Notable Movers - Anthem (ANTM), Novartis (NVS ...  Techsonian (press release)
Anthera Pharma spikes 30% on continuation of lupus study (ANTH)
Thinly-traded nano cap Anthera Pharmaceuticals (ANTH +31.2%) jumps on a whopping 14x surge in volume in response to the company's announcement that its Phase 3 trial assessing blisibimod for the treatment of patients with systemic lupus ...
Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase ...  PR Newswire (press release)
Company Shares of Anthera Pharmaceuticals Inc Rally 1.6%
Shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH) appreciated by 1.6% during the past week but lost 3.42% on a 4-week basis.
Anthera jumps as interest in lupus med builds (ANTH)
Thinly-traded nano cap Anthera Pharmaceuticals (ANTH +32.6%) jumps on a bullish 16x surge in volume. The company has a symposium on systemic lupus erythematosus scheduled for next week in San Francisco.